Neurology
Show:
Nov 15, 2023
Alzheimer’s Disease and Dementia: What Healthcare Practitioners Need to Know
Alzheimer’s disease, the most common cause of dementia, is the seventh-leading cause of death in the U.S. Early diagnosis provides important benefits to diagnosed individuals and their loved ones, caregivers, and society.
Professional Education
Loss Lessons: Recognition of Wernicke Encephalopathy
Wernicke encephalopathy (WE) is a syndrome commonly seen in patients with alcohol use disorder who do not take adequate thiamine. WE should be suspected in any patient with conditions that may lead to malnutrition in combination with any of the following symptoms: altered mental status ophthalmoplegia, ataxia, delirium, and hypotension. Considered a medical emergency, it must be reversed to prevent permanent deficits. This case illustrates a cascade of errors which led to permanent disability. Some practical interventions to quickly recognize and reverse the condition are offered following the case presentation, which will be helpful for gastroenterology/gastroenterologists, ophthalmology/ophthalmologists, and neurology/neurologists.
Professional Education
Alzheimer's 7: Questions and Answers - What Physicians Ask About Diagnosing and Treating Dementia
This course focuses on the common concerns and questions expressed by clinicians about dementia and cognitive impairment. Practitioners will learn more about making the initial observation of cognitive decline and beginning a conversation with older adult patients, overcoming common barriers to making a definitive diagnosis of dementia, and managing the ongoing clinical needs of patients experiencing dementia. Experienced clinicians engage in conversation on how they handle delicate and difficult conversations with patients and their family members. Program participants will become knowledgeable of warning signs of dementia, gain proficiency in screening and evaluating adults for cognitive deficits, confidently disclose a diagnosis of dementia, and communicate next steps to patients and family caregivers, including safety issues, medications, and community resources. [1.50 AMA PRA Category 1 Credits™, 1.50 Contact Hours (ANCC)]
Professional Education
Alzheimer's 6: Pharmacological Management of Behavioral and Psychological Symptoms of Dementia
Join our self-paced educational program to learn to distinguish dementia symptoms from other psychiatric issues and treat them with pharmacological interventions. Improve recognition of behavioral problems in Alzheimer's and dementia patients, use the DICE psycho-behavioral model for medication decisions, and create treatment plans with behavioral and pharmacological strategies to refine your best practices for individuals with dementia. [1.50 AMA PRA Category 1 Credits™, 1.50 Contact Hours (ANCC)]
Professional Education
Alzheimer's 5 : Use of Pharmacotherapy for Patients with Major Neurocognitive Disorder
This activity includes video lectures and is the fifth in a series of courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer's disease and related dementias. This fifth course focuses on the most frequently used and FDA-approved prescription medications for Alzheimer's disease and dementias, the current research regarding its use, and guidelines for prescribing and discontinuing medication. The program will incorporate cultural values and beliefs when creating and sharing the pharmacological care plan. [1.75 AMA PRA Category 1 Credits™, 1.75 Contact Hours (ANCC)]
Professional Education
Alzheimer's 4: Addressing Patients' and Families' Needs through the Disease Stages of Dementia
This is the fourth session in an eight-part educational series that focuses on standardized screening, evaluation, and disease management of Alzheimer’s disease and related dementias. This course covers life planning throughout disease stages, assessing and assisting caregivers, enhancing communications, utilizing community resources, and end-of-life decision-making. It addresses sensitive conversations with patients, families, and caregivers. [2.00 AMA PRA Category 1 Credits™, 2.00 Contact Hours (ANCC)]
Professional Education
Alzheimer's 2: Evaluation and Diagnosis of Alzheimer’s Disease and Related Dementias
This activity is the second in a series of eight courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer’s disease and related dementias. This second course includes video lectures and introduces the Alzheimer’s project evaluation algorithm and evaluation instruments with a focus on differential diagnoses. Finally, the course discusses how to prepare and engage in a sensitive dementia diagnosis disclosure with patients and caregivers. [1.75 AMA PRA Category 1 Credits™, 1.75 Contact Hours (ANCC)]
Professional Education
Alzheimer's 3: Addressing and Managing Behavioral and Environmental Symptoms of Dementia
This activity is the third in a series of eight courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer’s disease and related dementias. This third course focuses on using the DICE method to assess behavioral symptoms of dementia and create and evaluate treatment plans. This course also covers the careful use of medication during disease management and common behavioral issues with dementia patients including tools for management of these behaviors. [1.50 AMA PRA Category 1 Credits™, 1.75 Contact Hours (ANCC)]
Professional Education
Alzheimer's 1: Screening for Dementia Among Adults with Cognitive Decline
This activity is the first in a series of eight courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer’s disease and related dementias. This first course focuses on introducing the Alzheimer’s Project and highlighting the increasingly important role of practitioners in dementia care. The course also introduces the Alzheimer’s Project cognitive impairment screening algorithm and screening instruments and covers addressing reversible conditions that may present similar symptoms to cognitive impairment. [1.25 AMA PRA Category 1 Credits™, 1.25 Contact Hours (ANCC)]
Aug 04, 2021
Cognitive Assessments in Primary Care: Preparation and Tools May Mitigate Diagnosis Risks
Recent reimbursement changes by the Centers for Medicare and Medicaid Services (CMS) allow primary care providers to meet their patients’ mental health needs and help build their practices by performing cognitive assessments.